O'Shaughnessy Asset Management, LLC Fibrogen Inc Transaction History

O'Shaughnessy Asset Management, LLC

  • $10.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$9.93 - $15.39 $40,166 - $62,252
-4,045 Closed
0 $0
Q3 2021

Nov 10, 2021
SELL
$10.18 - $26.64 $3,461 - $9,057
-340 Reduced 7.75%
4,045 $41,000
Q2 2021

Aug 09, 2021
BUY
$18.57 - $35.68 $32,608 - $62,654
1,756 Added 66.79%
4,385 $117,000
Q4 2020

Feb 11, 2021
BUY
$37.09 - $48.97 $97,509 - $128,742
2,629 New
2,629 $97,000

Others Institutions Holding FGEN

# of Institutions
82
Shares Held
47.1M
Call Options Held
387K
Put Options Held
672K
View Full List

About FIBROGEN INC

FGEN Quotes by TradingView
  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $32.8M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track O'Shaughnessy Asset Management, LLC Portfolio

Follow O'Shaughnessy Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email